艰难梭菌毒素蛋白B促进巨噬细胞产生pro-IL-1β的作用机制研究
结题报告
批准号:
81971993
项目类别:
面上项目
资助金额:
54.0 万元
负责人:
彭奕冰
依托单位:
学科分类:
免疫学检验
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
彭奕冰
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
艰难梭菌毒素蛋白B刺激巨噬细胞产IL-1β是引发宿主肠道炎症风暴的关键。IL-1β由pro -IL-1β经切割产生。毒素B可促进pro-IL-1β的产生,但其机制不明。我们前期结果显示:毒素B通过活化p38MAPK信号通路促进pro-IL-1β产生,此过程依赖经典接头蛋白MyD88;FZD5作为可能的巨噬细胞表面毒素B受体,在毒素B刺激下可与MyD88结合。因此我们推测:毒素B可能与FZD5或其他受体结合,招募MyD88,进而活化下游信号通路促进pro-IL-1β产生。本课题首先验证MyD88对pro-IL-1β形成的作用,采用免疫共沉淀与荧光共定位技术研究MyD88和受体的相互作用,构建受体敲除细胞株以明确受体的功能,最终通过体内外实验揭示毒素蛋白B促巨噬细胞产pro-IL-1β的机制。本课题对进一步了解艰难梭菌在肠炎中的致病机制、寻找艰难梭 菌肠炎的免疫治疗新靶点具有重要意义。
英文摘要
The production of IL-1β stimulated by Clostridium difficile toxinB in macrophages is an important cause intestinal inflammatory storms. IL-1β is the cleavage product of pro-IL-1β. However the mechanism of how toxin B could produce pro- IL-1β is still unclear. Previous results showed that toxin B promoted pro-IL-1β production by activating the p38 MAPK signaling pathway, which depended on the canonical adaptor protein MyD88. Upon the stimulation of toxin B, FZD5, a possible macrophage surface toxin B receptor, was able to bind MyD88. Therefore, we presume that toxin B may bind to the FZD5 or other receptors and recruit MyD88, which in turn activate downstream signaling pathways to promote the production of pro-IL-1β. In this project, we will firstly verify the effect of MyD88 on pro-IL-1β formation, then observe the interaction between MyD88 and the receptor by immunoprecipitation and fluorescence co-localization, define the function of the receptor through constructing the receptor gene knockout cell line, and finally elucidate the mechanism of toxin B promoting macrophage production of pro-IL-1β both in vitro and in vivo. The goal of this project is to further understand the pathogenic mechanism of C. difficile in intestinal inflammation and to find new targets for immunotherapy of C. difficile enteritis.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1038/s41467-023-43945-1
发表时间:2023-12-20
期刊:NATURE COMMUNICATIONS
影响因子:16.6
作者:Dong, Danfeng;Du, Yuzhang;Fei, Xuefeng;Yang, Hao;Li, Xiaofang;Yang, Xiaobao;Ma, Junrui;Huang, Shu;Ma, Zhihui;Zheng, Juanjuan;Chan, David W.;Shi, Liyun;Li, Yunqi;Irving, Aaron T.;Yuan, Xiangliang;Liu, Xiangfan;Ni, Peihua;Hu, Yiqun;Meng, Guangxun;Peng, Yibing;Sadler, Anthony;Xu, Dakang
通讯作者:Xu, Dakang
Complete Genome Sequencing and Comparative Phenotypic Analysis Reveal the Discrepancy Between Clostridioides difficile ST81 and ST37 Isolates.
完整的基因组测序和比较表型分析揭示了艰难梭菌 ST81 和 ST37 分离株之间的差异
DOI:10.3389/fmicb.2021.776892
发表时间:2021
期刊:Frontiers in microbiology
影响因子:5.2
作者:Su T;Chen W;Wang D;Cui Y;Ni Q;Jiang C;Dong D;Peng Y
通讯作者:Peng Y
DOI:10.1186/s12866-023-03069-4
发表时间:2023-10-28
期刊:BMC MICROBIOLOGY
影响因子:4.2
作者:Ni, Qi;Wu, Xianwei;Su, Tongxuan;Jiang, Cen;Dong, Danfeng;Wang, Daosheng;Chen, Wei;Cui, Yingchao;Peng, Yibing
通讯作者:Peng, Yibing
DOI:10.1186/s13054-023-04412-x
发表时间:2023-03-28
期刊:CRITICAL CARE
影响因子:15.1
作者:Sun, Silei;Wang, Daosheng;Dong, Danfeng;Xu, Lili;Xie, Mengqi;Wang, Yihui;Ni, Tongtian;Jiang, Weisong;Zhu, Xiaojuan;Ning, Ning;Sun, Qian;Zhao, Shuyuan;Li, Mengjiao;Chen, Peili;Yu, Meiling;Li, Jian;Chen, Erzhen;Zhao, Bing;Peng, Yibing;Mao, Enqiang
通讯作者:Mao, Enqiang
Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units
危险因素和肠道微生物群:在重症监护病房接受肠内营养的患者中艰难梭菌感染
DOI:10.1186/s13054-020-03119-7
发表时间:2020-07
期刊:Critical Care
影响因子:15.1
作者:Daosheng Wang;Danfeng Dong;Chen Wang;Yingchao Cui;Cen Jiang;Qi Ni;Tongxuan Su;Guanzheng Wang;Enqiang Mao;Yibing Peng
通讯作者:Yibing Peng
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    彭奕冰
  • 依托单位:
murJ插入突变增强艰难梭菌抵抗巨噬细胞杀伤能力的机制研究
  • 批准号:
    82172324
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2021
  • 负责人:
    彭奕冰
  • 依托单位:
转录因子UME6调控氧化应激相关基因SOD2表达介导热带假丝酵母菌毒力增强的机制研究
  • 批准号:
    81572053
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2015
  • 负责人:
    彭奕冰
  • 依托单位:
转录因子PDR1调控PUP1调节光滑假丝酵母菌氧化应激介导其对唑类药物耐药机制研究
  • 批准号:
    81371873
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    彭奕冰
  • 依托单位:
国内基金
海外基金